期刊文献+

microRNA特异性表达对肺癌的诊断及预后的临床意义 被引量:1

Clinical significance of microRNA specific expression in diagnosis and prognosis of lung cancer
原文传递
导出
摘要 microRNA是一类具有非编码功能的RNA,在植物、病毒以及人类中广泛存在,其参与人体多个生理过程,具有显著的调节作用。microRNA能够与mRNA结合从而使mRNA酶降解,即可阻断相应蛋白的编码,对其生物学功能造成改变和影响。最近几年的发现表明,microRNA与众多肺癌的发生、发展、诊断、治疗、预后等密切相关。肺癌是具有高发病率、低治疗率、高致死率的一种肺癌,成为危害人们生命健康的头号杀手。研究表明,microRNA在肺癌疾病的诊断筛查等过程中具有显著的特异度和敏感度。本文分析了microRNA的产生机制,并对microRNA特异性表达对肺癌诊断及预后生物学标志物方法进行了认真分析探讨,这为microRNA在肺癌诊断、治疗和预后方面的临床价值提供参考依据。 MicroRNA is a type of RNA with non-coding functions.It exists widely in plants,viruses,and humans.It participates in many physiological processes of the human body and has significant regulatory effects.MicroRNA can bind to mRNA to degrade mRNA enzyme,which can block the coding of the corresponding protein and cause changes and effects on its biological function.The findings in recent years indicate that microRNA is closely related to the occurrence,development,diagnosis,treatment,and prognosis of many lung cancers.Lung cancer is a kind of lung cancer with high morbidity,low treatment rate and high lethality,and it has become the number one killer that endangers people′s life and health.Studies have shown that microRNAs have significant specificity and sensitivity in the diagnosis and screening of lung cancer diseases.This article analyzes the mechanism of microRNA production,and carefully analyzes the specific expression of microRNAs in the diagnosis and prognosis of lung cancer.It provides a reference for the clinical value of microRNA in the diagnosis,treatment and prognosis of lung cancer.
作者 张东伟 蓝冰 钟家将 Zhang Dongwei;Lan Bing;Zhong Jiajiang(Department of Respiratory and Critical Care Medicine,People′s Hospital of Liuzhou City,Liuzhou 545000,China)
出处 《国际呼吸杂志》 2020年第10期773-778,共6页 International Journal of Respiration
基金 广西卫健委自筹经费科研课题(Z20190032) 柳州市人民医院院内课题(lryjc201908)。
关键词 微RNAS 肺肿瘤 细胞诊断学 预后 生物学标记 MicroRNAs Lung neoplasms Cytodiagnosis Prognosis Biological markers
  • 相关文献

参考文献17

二级参考文献76

  • 1潘雁,徐云华,王韡旻,朱珺.非小细胞肺癌患者生命质量的影响因素分析[J].上海交通大学学报(医学版),2011,31(3):339-342. 被引量:11
  • 2万崇华,陈明清,张灿珍,汤学良,孟琼,张晓磬.癌症患者生命质量测定量表EORTC QLQ-C30中文版评介[J].实用肿瘤杂志,2005,20(4):353-355. 被引量:1338
  • 3曾显声,周燕斌.肺癌血清肿瘤标志物的研究现状[J].国际内科学杂志,2007,34(2):73-76. 被引量:51
  • 4JEMAL A, BRAY F, CENTER M M, et al. Global cancer statistics [ J ] . CA Cancer J Clin, 2011, 61(2): 69-90.
  • 5ERRIDGE S C, MOLLER H, PRICE A, et al. International comparisons of survival from lung cancer: pitfalls and warnings [ J ] . Nat Clin Pract Oncol, 2007, 4(10): 570-577.
  • 6HEES K, LEBEAU P B. Comparison of conventional and ThinPrep preparations of mucoid cytology samples [ J ]. Diagn Cytopathol, 1995, 12(2): 181-185.
  • 7MUKHOPADHYAY S, KATZENSTEIN A L. Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6 [ J ] , Am J Surg Pathol, 2011, 5(1): 15-25.
  • 8NG W K, CHOW J C, NG P K. Thyroid transcription factor-1 is highly sensitive and specific in differentiating metastatic pulmonary from extrapulmonary adenocarcinoma in effusion fluid cytology specimens [ J ] . Cancer, 2002, 96(1): 43-48.
  • 9KHAYYATA S, YUN S, PASHA T, et al. Value of p63 and CK5/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine-needle aspiration specimens [ J ]. Dign Cytopathol, 2009, 37(3): 178-183.
  • 10BOKHOVEN H, BRUNNER H G. Splitting p63 [ J ] . Am J Hum Genet, 2002, 71(1):1-13.

共引文献93

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部